These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14454972)

  • 1. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.
    KELLERMEYER RW; TARLOV AR; BREWER GJ; CARSON PE; ALVING AS
    JAMA; 1962 May; 180():388-94. PubMed ID: 14454972
    [No Abstract]   [Full Text] [Related]  

  • 2. The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis.
    BREWER GJ; TARLOV AR; ALVING AS
    JAMA; 1962 May; 180():386-8. PubMed ID: 13872968
    [No Abstract]   [Full Text] [Related]  

  • 3. The hemolytic effect of primaquine. XIII. Gradient susceptibility to hemolysis of primaquine-sensitive erythrocytes.
    KELLERMEYER RW; TARLOV AR; SCHRIER SL; CARSON PE; ALVING AS
    J Lab Clin Med; 1961 Aug; 58():225-33. PubMed ID: 13752331
    [No Abstract]   [Full Text] [Related]  

  • 4. Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance.
    TARLOV AR; BREWER GJ; CARSON PE; ALVING AS
    Arch Intern Med; 1962 Feb; 109():209-34. PubMed ID: 13919680
    [No Abstract]   [Full Text] [Related]  

  • 5. The hemolytic effect of primaquine. XI. Decreased catalase activity in primaquine-sensitive erythrocytes.
    TARLOV AR; KELLERMEYER RW
    J Lab Clin Med; 1961 Aug; 58():204-16. PubMed ID: 13775336
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of the administration of fava beans and primaquine on glucose-6-phosphate dehy-drogenase-deficient erythrocytes labeled with Cr-51].
    PANIZON F; VULLO C
    Haematologica; 1962; 47():205-14. PubMed ID: 14483539
    [No Abstract]   [Full Text] [Related]  

  • 7. The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes.
    SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
    J Lab Clin Med; 1959 Aug; 54():232-40. PubMed ID: 14443591
    [No Abstract]   [Full Text] [Related]  

  • 8. IN VIVO GENERATION OF H2O2 IN MOUSE ERYTHROCYTES BY HEMOLYTIC AGENTS.
    COHEN G; HOCHSTEIN P
    J Pharmacol Exp Ther; 1965 Jan; 147():139-43. PubMed ID: 14255158
    [No Abstract]   [Full Text] [Related]  

  • 9. Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity.
    BREWER GJ; TARLOV AR; ALVING AS
    Bull World Health Organ; 1960; 22(6):633-40. PubMed ID: 13804322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hemolytic effect of primaquine. XV. Role of methemoglobin.
    BREWER GJ; TARLOV AR; KELLERMEYER RW; ALVING AS
    J Lab Clin Med; 1962 Jun; 59():905-17. PubMed ID: 13872969
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Primaquine on the red blood cell membrane. II. Potassium ion permeability in glucose-6-phosphate dehydrogenase deficient erythrocytes.
    WEED RI
    J Clin Invest; 1961 Jan; 40(1):140-3. PubMed ID: 13783700
    [No Abstract]   [Full Text] [Related]  

  • 12. The hemolytic effect of various sulfonamides on subjects with a deficiency of glucose-6-phosphate dehydrogenase of erythrocytes.
    SZEINBERG A; PRAS M; SHEBA C; ADAM A; RAMOT B
    Isr Med J; 1959; 18():176-83. PubMed ID: 13836343
    [No Abstract]   [Full Text] [Related]  

  • 13. GENERATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES BY HEMOLYTIC AGENTS.
    COHEN G; HOCHSTEIN P
    Biochemistry; 1964 Jul; 3():895-900. PubMed ID: 14214074
    [No Abstract]   [Full Text] [Related]  

  • 14. The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes.
    BEUTLER E; DERN RJ; ALVING AS
    J Lab Clin Med; 1954 Aug; 44(2):177-84. PubMed ID: 13184225
    [No Abstract]   [Full Text] [Related]  

  • 15. Primaquine sensitivity of erythrocytes.
    CHILDS B
    Arch Intern Med; 1961 Feb; 107():151-3. PubMed ID: 13693095
    [No Abstract]   [Full Text] [Related]  

  • 16. The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes.
    SCHRIER SL; KELLERMEYER RW; CARSON PE; ICKES CE; ALVING AS
    J Lab Clin Med; 1958 Jul; 52(1):109-17. PubMed ID: 13549855
    [No Abstract]   [Full Text] [Related]  

  • 17. The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine.
    BEUTLER E; DERN RJ; ALVING AS
    J Lab Clin Med; 1955 Jan; 45(1):40-50. PubMed ID: 13233626
    [No Abstract]   [Full Text] [Related]  

  • 18. The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes.
    BEUTLER E; DERN RJ; FLANAGAN CL; ALVING AS
    J Lab Clin Med; 1955 Feb; 45(2):286-95. PubMed ID: 13233657
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxidative hemolysis and precipitation of hemoglobin. I. Heinz body anemias as an acceleration of red cell aging.
    JANDL JH; ENGLE LK; ALLEN DW
    J Clin Invest; 1960 Dec; 39(12):1818-36. PubMed ID: 13789379
    [No Abstract]   [Full Text] [Related]  

  • 20. HEMOLYTIC EFFECT OF PRIMAQUINE. XVI. GLYOXALASE ACTIVITY OF PRIMAQUINE-SENSITIVE AND NORMAL ERYTHROCYTES.
    BREWER GJ; POWELL RD; TARLOV AR; ALVING AS
    J Lab Clin Med; 1964 Jan; 63():106-21. PubMed ID: 14102892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.